207 related articles for article (PubMed ID: 27473713)
1. Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand.
Phueanpinit P; Pongwecharak J; Krska J; Jarernsiripornkul N
Int J Clin Pharm; 2016 Oct; 38(5):1269-76. PubMed ID: 27473713
[TBL] [Abstract][Full Text] [Related]
2. Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients.
Phueanpinit P; Pongwecharak J; Sumanont S; Krska J; Jarernsiripornkul N
J Eval Clin Pract; 2017 Dec; 23(6):1387-1394. PubMed ID: 28809071
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand.
Phueanpinit P; Pongwecharak J; Krska J; Jarernsiripornkul N
Prim Health Care Res Dev; 2018 Nov; 19(6):598-604. PubMed ID: 29551098
[TBL] [Abstract][Full Text] [Related]
4. Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand.
Jarernsiripornkul N; Phueanpinit P; Pongwecharak J; Krska J
Expert Opin Drug Saf; 2016; 15(4):417-26. PubMed ID: 26742855
[TBL] [Abstract][Full Text] [Related]
5. Practices of healthcare professionals in communicating with nonsteroidal anti-inflammatory drug users in Thailand: a qualitative study.
Jarernsiripornkul N; Phueanpinit P; Pongwecharak J; Krska J
Int J Pharm Pract; 2019 Aug; 27(4):362-369. PubMed ID: 30912610
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
7. Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand.
Phueanpinit P; Jarernsiripornkul N; Pongwecharak J; Krska J
Int J Clin Pharm; 2014 Dec; 36(6):1205-12. PubMed ID: 25288144
[TBL] [Abstract][Full Text] [Related]
8. Prescription pattern of NSAIDs and the prevalence of NSAID-induced gastrointestinal risk factors of orthopaedic patients in clinical practice in Korea.
Lee SH; Han CD; Yang IH; Ha CW
J Korean Med Sci; 2011 Apr; 26(4):561-7. PubMed ID: 21468265
[TBL] [Abstract][Full Text] [Related]
9. Risk perception of NSAIDs in hospitalized patients in Greece.
Karakitsiou M; Varga Z; Kriska M; Kristova V
Bratisl Lek Listy; 2017; 118(7):427-430. PubMed ID: 28766354
[TBL] [Abstract][Full Text] [Related]
10. High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study.
Koffeman AR; Valkhoff VE; Celik S; W't Jong G; Sturkenboom MC; Bindels PJ; van der Lei J; Luijsterburg PA; Bierma-Zeinstra SM
Br J Gen Pract; 2014 Apr; 64(621):e191-8. PubMed ID: 24686883
[TBL] [Abstract][Full Text] [Related]
11. The attitudes of owners and veterinary professionals in the United Kingdom to the risk of adverse events associated with using non-steroidal anti-inflammatory drugs (NSAIDs) to treat dogs with osteoarthritis.
Belshaw Z; Asher L; Dean RS
Prev Vet Med; 2016 Sep; 131():121-126. PubMed ID: 27544261
[TBL] [Abstract][Full Text] [Related]
12. Use of gastroprotective agents in recommended doses in hospitalized patients receiving NSAIDs: a drug utilization study.
Erdeljic V; Francetic I; Macolic Sarinic V; Bilusic M; Makar Ausperger K; Huic M; Mercep I
Pharm World Sci; 2006 Oct; 28(5):318-25. PubMed ID: 17111239
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal symptoms in NSAID users in an 'average risk population': results of a large population-based study in randomly selected Dutch inhabitants.
Tielemans MM; van Rossum LG; Eikendal T; Focks JJ; Laheij RJ; Jansen JB; van Oijen MG
Int J Clin Pract; 2014 Apr; 68(4):512-9. PubMed ID: 24499203
[TBL] [Abstract][Full Text] [Related]
14. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
15. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.
Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G
Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prescribing patterns of nonsteroidal anti-inflammatory agents in a tertiary setting.
Khalil V; Wang W; Charlson L; Blackley S
Int J Evid Based Healthc; 2019 Sep; 17(3):164-172. PubMed ID: 31211729
[TBL] [Abstract][Full Text] [Related]
17. What do patients in rheumatologic care know about the risks of NSAIDs?
Ornbjerg LM; Andersen HB; Kryger P; Cleal B; Hetland ML
J Clin Rheumatol; 2008 Apr; 14(2):69-73. PubMed ID: 18391673
[TBL] [Abstract][Full Text] [Related]
18. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
Scheiman JM; Hindley CE
Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
[TBL] [Abstract][Full Text] [Related]
19. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
20. Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients.
Lee YC; Chang CH; Lin JW; Chen HC; Lin MS; Lai MS
Liver Int; 2012 May; 32(5):859-66. PubMed ID: 22226322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
